DEGLI UBERTI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 29.055
AS - Asia 14.217
EU - Europa 9.961
SA - Sud America 2.411
AF - Africa 251
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 19
Totale 55.934
Nazione #
US - Stati Uniti d'America 28.507
SG - Singapore 5.777
CN - Cina 4.416
DE - Germania 3.089
BR - Brasile 2.069
UA - Ucraina 1.992
HK - Hong Kong 1.342
TR - Turchia 1.180
IT - Italia 1.120
GB - Regno Unito 925
RU - Federazione Russa 735
VN - Vietnam 720
FI - Finlandia 716
SE - Svezia 531
MX - Messico 260
PL - Polonia 255
CA - Canada 230
FR - Francia 191
IN - India 162
AR - Argentina 144
ZA - Sudafrica 124
BD - Bangladesh 103
JP - Giappone 93
ID - Indonesia 84
ES - Italia 75
NL - Olanda 73
BE - Belgio 71
IQ - Iraq 61
EC - Ecuador 53
PK - Pakistan 43
LT - Lituania 41
MA - Marocco 35
AT - Austria 33
UZ - Uzbekistan 32
VE - Venezuela 32
CO - Colombia 28
PY - Paraguay 28
IR - Iran 27
KE - Kenya 20
SA - Arabia Saudita 20
CL - Cile 19
AE - Emirati Arabi Uniti 18
TN - Tunisia 18
AU - Australia 15
CZ - Repubblica Ceca 15
IE - Irlanda 15
NP - Nepal 15
EU - Europa 14
UY - Uruguay 14
IL - Israele 13
PE - Perù 13
EG - Egitto 12
RO - Romania 12
DO - Repubblica Dominicana 11
DZ - Algeria 11
JO - Giordania 11
LB - Libano 11
TT - Trinidad e Tobago 11
MY - Malesia 10
AZ - Azerbaigian 9
AL - Albania 8
BG - Bulgaria 8
BO - Bolivia 8
DK - Danimarca 8
CH - Svizzera 7
JM - Giamaica 7
KG - Kirghizistan 7
KZ - Kazakistan 7
PH - Filippine 7
AM - Armenia 6
GA - Gabon 6
PA - Panama 6
PS - Palestinian Territory 6
PT - Portogallo 6
HN - Honduras 5
MD - Moldavia 5
OM - Oman 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
GT - Guatemala 4
HU - Ungheria 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BH - Bahrain 3
BY - Bielorussia 3
CY - Cipro 3
ET - Etiopia 3
GE - Georgia 3
KR - Corea 3
KW - Kuwait 3
LV - Lettonia 3
ML - Mali 3
NG - Nigeria 3
NI - Nicaragua 3
QA - Qatar 3
SN - Senegal 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
Totale 55.891
Città #
Singapore 3.480
Woodbridge 3.027
Ashburn 2.867
Fairfield 2.449
Jacksonville 2.160
Chandler 2.078
Houston 1.758
Beijing 1.417
Santa Clara 1.388
Hong Kong 1.337
Ann Arbor 1.271
Seattle 966
Wilmington 951
Cambridge 747
Izmir 677
Nanjing 619
Los Angeles 467
Princeton 440
Dallas 415
Munich 399
Addison 384
New York 364
San Diego 277
Boardman 269
Ho Chi Minh City 255
Warsaw 246
Milan 234
São Paulo 217
Shanghai 200
Shenyang 198
Mexico City 182
Helsinki 180
Nanchang 180
Dearborn 163
Hanoi 156
Turku 137
Ferrara 135
Hebei 134
Tianjin 129
Hefei 127
Changsha 117
Washington 113
Bremen 109
London 101
Buffalo 100
Jiaxing 97
Brooklyn 94
Orem 89
Montreal 88
Tokyo 86
Denver 85
Jinan 84
Chicago 78
Johannesburg 73
Falls Church 69
Mountain View 67
Boston 66
San Francisco 65
Brussels 64
Moscow 64
San Mateo 62
Poplar 61
Phoenix 59
Stockholm 59
Belo Horizonte 57
Chennai 57
Rio de Janeiro 54
San Jose 54
Toronto 54
Atlanta 52
Kunming 49
Guangzhou 48
Norwalk 48
Zhengzhou 48
Falkenstein 45
Frankfurt am Main 45
Ningbo 45
Redwood City 45
The Dalles 45
Carrara 40
Ankara 37
Auburn Hills 36
Manchester 36
Nuremberg 36
Rome 36
Tappahannock 36
Brasília 34
Taizhou 34
Augusta 33
Jakarta 32
Porto Alegre 31
Council Bluffs 30
Leawood 30
Baghdad 29
Haiphong 29
Amsterdam 28
Charlotte 28
Düsseldorf 28
Orange 28
Campinas 27
Totale 36.454
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 397
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 285
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 242
ROLL technique application for Minimally-Invasive Radioguided Parathyroidectomy (MIRP) in Hyperparathyroidism (HPT) 240
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 234
Igf-I influences everolimus activity in medullary thyroid carcinoma 227
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 224
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 221
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 219
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 218
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 214
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 214
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 212
Characterization of a deleted Y chromosome in a male with Turner stigmata 210
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 208
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 208
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 207
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 205
Circadian profile of plasma calcitonin gene-related peptide in healthy man 202
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 202
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 201
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 200
A c-myc gene variant without exon 1 and with an abnormal methylation pattern inherited in a woman with no evidence of malignancy 199
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 198
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 198
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 198
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 195
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 195
Dermorphin inhibits spinal nociceptive flexion reflex in humans 194
A practical method for the estimation of therapeutic activity in the treatment of Graves' hyperthyroidism 194
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 193
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 193
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 191
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 189
Functional characterization of a new deletion in CDKN1B 5'-UTR region 189
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 188
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 188
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 187
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 187
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 185
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 185
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 184
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 183
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 183
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 183
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 181
Evidence for androgen receptor gene expression in human thyroid cells and tumours 181
Evaluation of ''ROLL-like'' procedure for minimallyinvasive radioguided parathyroidectomy (MIRP) in hyperparathyroidism (HPT). 181
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 180
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 179
c-myc oncogene alterations in human thyroid carcinomas. 179
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 179
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 177
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 177
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 176
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 176
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 176
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 176
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 174
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 174
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 174
Growth hormone excess promotes breast cancer chemoresistance 174
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 174
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 173
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 172
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 171
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 171
Growth hormone induces chemoresistance in breast cancer cells 171
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 171
Antiproliferative effects of somatostatin analogs in pituitary adenomas 170
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 170
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 170
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 170
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 170
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 168
Detection of androgen receptor (AR) mRNA by the reverse transcription polymerase chain reaction (RT-PCR) in human thyroids. 168
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 168
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 168
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 168
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 168
Diurnal rhythm of plasma catecholamines in acromegaly 167
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 167
Circadian variations of plasma TSH in patients with severe hypothyroidism 166
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 166
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 166
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 165
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 165
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 165
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 165
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide 163
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 163
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 163
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 163
miR-15a and miR-16-1 down-regulation in pituitary adenomas 163
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 163
Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach 163
Atrial strain is the main determinant of release of atrial natriuretic peptide 161
Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man 161
Pituitary side effects of old and new drugs. 161
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 161
Totale 18.721
Categoria #
all - tutte 252.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 16.850
Totale 269.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.618 0 0 0 0 0 495 115 520 68 522 688 210
2021/20224.080 129 416 246 180 192 186 164 183 164 338 437 1.445
2022/20234.399 443 303 175 595 687 658 179 383 578 32 214 152
2023/20242.338 200 274 132 62 204 382 71 462 40 28 34 449
2024/20258.348 230 180 625 210 1.067 876 307 351 1.297 985 1.247 973
2025/202613.628 2.330 980 2.087 3.099 3.895 1.237 0 0 0 0 0 0
Totale 56.245